USA
- EU Hub: Hungary
- Bosnia & Herzegovina
- Croatia
- Denmark
- Georgia
- Ireland
- Moldova
- Montenegro
- North Macedonia
- Serbia
- UK
- Ukraine
- Egypt
- Israel
- Saudi Arabia
- Turkiye
- Sub Saharan Africa Hub: Kenya
- South Africa
- Canada
- Dominican Republic
- USA
- Argentina
- Brazil
- Chile
- Colombia
- Costa Rica
- Guatemala
- Panama
- Australia
- China
- India
Service offered
Service offered upon request
Depot type
Canada
USA
Dominican Republic
Oximio’s Central Depots
Oximio’s Partner Depots
Products Managed
Antibiotic
Biological Goods
Blood Product or Derivative
Controlled Drugs on Request
Cytotoxic
Dangerous Goods
Genetically Modified Organism
Radioactive
Ancillary Supply/Equipment
Temperature Conditions
Ambient (non-controlled)
Ambient (+15°C to +25°C)
Refrigerated (+2°C to +8°C)
Frozen (-25ºC to -15ºC)
Deep Frozen (-80ºC to -60ºC)
LN2 (Cryogenic)
Certifications
GDP License
GMP Certification
ISO9001:2015
MIA Certification
WHL License
Controlled Drugs License
MDEL license
Services
Labeling (JIT)
Primary Packaging
Secondary Packing
Comparator sourcing
IOR
DTP (direct to patient)
DTS (direct to site)
USA
Depot Location
Oximio Resources
See all resources-
CASE STUDY • APR 2026
Supporting a Small Biotech to Deliver a Critical Phase III Clinical Trial in Canada
Read more
-
-
INSIGHTS • FEB 2026
Why Local Pharmacovigilance Matters: The Critical Role of the LQPPV in Kenya
Read more
-
NEWS • FEB 2026
New Location Opening in Saudi Arabia – Oximio Strengthens Middle East Presence
Read more
-
